ReviewTranslational psychiatry2025
Subtyping schizophrenia via machine learning by using structural neuroimaging.
Review in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Subtyping psychotic disorders using a data-driven approach reveals divergent cortical and cellular signatures.Molecular psychiatry · 2026Article
- Cerebellar dysconnectivity in schizophrenia spectrum: task-based functional connectivity analysis and cognitive stratification.Frontiers in psychiatry · 2026Article
- Machine learning for immune biomarkers in severe mental illness: a systematic review.Neuroscience applied · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a heterogeneous disorder with diverse clinical presentations and neuroanatomical alterations. Despite recent advances, we still lack a working hypothesis for the pathophysiology of schizophrenia. One reason might be the heterogeneous neuroanatomy of the patients. Data-driven approaches leveraging structural neuroimaging and machine learning have emerged as transformative tools for unraveling this enigma. Recent studies employing advanced clustering techniques have identified robust neuroanatomical subtypes independent of traditional symptom-based frameworks. These data-driven methods reveal distinct cortical and subcortical patterns, aligning with disease progression variations, cognitive function, and treatment outcomes. Novel trajectory-based models suggest that schizophrenia may originate from distinct neuroanatomical regions and follow divergent paths of progression, emphasizing the importance of understanding these patterns in the context of disease staging. These findings provide a foundation for improving diagnostic precision, understanding disease mechanisms, and tailoring interventions. Validation with longitudinal data and standardized methods is crucial for translating these insights into clinical practice and personalized treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.